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ABSTRACT
Objective: Pulmonary rehabilitation (PR) improves exercise capacity in most but not all 
COPD patients. The factors associated with treatment success and the role of chest wall 
mechanics remain unclear. We investigated the impact of PR on exercise performance 
in COPD with severe hyperinflation. Methods: We evaluated 22 COPD patients (age, 
66 ± 7 years; FEV1 = 37.1 ± 11.8% of predicted) who underwent eight weeks of aerobic 
exercise and strength training. Before and after PR, each patient also performed a six-
minute walk test and an incremental cycle ergometer test. During the latter, we measured 
chest wall volumes (total and compartmental, by optoelectronic plethysmography) and 
determined maximal workloads. Results: We observed significant differences between 
the pre- and post-PR means for six-minute walk distance (305 ± 78 vs. 330 ± 96 m, p < 
0.001) and maximal workload (33 ± 21 vs. 39 ± 20 W; p = 0.02). At equivalent workload 
settings, PR led to lower oxygen consumption, carbon dioxide production (VCO2), and 
minute ventilation. The inspiratory (operating) rib cage volume decreased significantly 
after PR. There were 6 patients in whom PR did not increase the maximal workload. 
After PR, those patients showed no significant decrease in VCO2 during exercise, had 
higher end-expiratory chest wall volumes with a more rapid shallow breathing pattern, 
and continued to experience symptomatic leg fatigue. Conclusions: In severe COPD, 
PR appears to improve oxygen consumption and reduce VCO2, with a commensurate 
decrease in respiratory drive, changes reflected in the operating chest wall volumes. 
Patients with severe post-exercise hyperinflation and leg fatigue might be unable to 
improve their maximal performance despite completing a PR program.
Keywords: Pulmonary disease, chronic obstructive/rehabilitation; Exercise therapy; 
Respiratory therapy.
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INTRODUCTION
Pulmonary rehabilitation (PR) is one of the most effective 
interventions in the management of COPD and produces 
significant improvements in exercise performance, with a 
reduction in breathlessness,(1-3) in patients with varying 
degrees of disease severity.(4) However, not all patients 
benefit from PR programs.(5) The reasons for this are 
complex; some patients decline to enroll in such programs, 
and some others initially recruited drop out, often due 
to factors related to expectation, smoking status, or 
perceived disability.(6) Relatively little is known about 
why some patients who complete the planned course 
of a PR program fail to improve.(7)
Most studies of PR programs have shown that, although 
rehabilitation has no effect on lung function, it can 
reduce carbon dioxide production (VCO2) and increase 
the lactate threshold.(6,8) It has been reported that lung 
and chest wall volumes decrease during exercise.(1,8,9) It 
remains unclear whether that is an effect of a reduced 
ventilatory demand for a given amount of work or whether 
rehabilitation changes the way in which COPD patients 
who have chronic hyperinflation breathe. The effect may 
be most relevant when resting hyperinflation is more 
severe. However, there are relatively few data about the 
impact of PR in hyperinflated patients with extremely poor 
initial exercise tolerance. We hypothesized that the main 
effect of PR in such patients would be to decrease the 
metabolic stimulus for ventilation during exercise and 
that any changes in the inspiratory (operating) chest wall 
volume would be secondary. In addition, we anticipated 
that the patients in whom there was no increase in CO2 
production during exercise (lack of such an increase 
being a marker of an impaired muscle performance) 
would not benefit from PR. Therefore, we aimed to 
investigate the impact that a general PR program has 
on exercise performance in COPD patients with severe 
hyperinflation and, consequently, worse baseline exercise 
performance than that of the COPD patients who have 
typically been studied. 
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METHODS
Patients and procedures
This was an exploratory observational study involving 
a convenience sample of 22 patients with moderate to 
very severe COPD(10) and a residual volume > 150% 
predicted. All were current or former smokers, with 
a post-bronchodilator FEV1/FVC ratio < 0.7 and FEV1 
< 70% of the predicted value. No patient had had an 
exacerbation in the last six weeks. All were treated with 
inhaled corticosteroids and long-acting bronchodilators, 
as well as short-acting rescue therapy when necessary. 
The exclusion criteria were having been diagnosed with 
asthma, requiring supplemental oxygen at rest, and 
having any concurrent illness that could limit exercise 
performance (including heart failure and neuromuscular 
disorders). The study was approved by the Research 
Ethics Committee of Aintree University Hospital, in 
Liverpool, England, and all participating patients gave 
written informed consent.
All measurements were performed before and 
after eight weeks of PR. Spirometry and lung volume 
measurements were performed using a plethysmograph 
(1085D; Medical Graphics Corporation, St. Paul, MN, 
USA), in accordance with the American Thoracic Society/
European Respiratory Society recommendations.(11,12) 
Maximal voluntary ventilation (MVV) was determined 
indirectly as the product of FEV1 × 37.5.(13) All variables 
are expressed as a percentage of the predicted value 
for age.(14,15)
Each patient performed two six-minute walk tests 
in accordance with the American Thoracic Society 
recommendations.(16) The six-minute walk distance 
(6MWD) was measured and compared with that obtained 
for an age-matched reference population evaluated 
in a study conducted in the city of Liverpool, United 
Kingdom.(17) Peripheral oxygen saturation and heart 
rate were recorded with a pulse oximeter (PULSOX 3i; 
Konica Minolta, Ramsey, NJ, USA). During the test, 
subjects were asked to rate their breathlessness and 
leg fatigue, on a modified Borg scale,(18) once every 
minute.
Optoelectronic plethysmography (OEP) was applied 
(see below), after which patients were seated on a 
cycle ergometer (Corival; Lode, Groningen, the Neth-
erlands) and asked to execute three slow vital capacity 
maneuvers, followed by 2 min of quiet breathing, to 
establish baseline values for the chest wall volumes. 
Subjects then undertook an incremental exercise test 
on a cycle ergometer, pedaling without a load for 2 
min, then with incremental load increases of 5 watts/
min until exhaustion. Subjects were breathing through 
a mouthpiece with a nose clip, and breath-by-breath 
ventilatory variables were derived from the flow signal 
detected with a pneumotachograph (preVent; Medical 
Graphics Corporation). Oxygen consumption (VO2) and 
VCO2 were measured with a paramagnetic sensor and 
an infrared carbon dioxide analyzer, respectively, as 
part of an exercise testing system (CardioO2 system; 
Medical Graphics Corporation). During the exercise, 
subjects were asked to rate their breathlessness and 
leg fatigue, on a modified Borg scale,(18) once every 
minute. The results were compared with those obtained 
for an age-matched population.(19) The flow signal was 
synchronized with that of the motion analyzer used 
for OEP and transferred to a personal computer for 
subsequent analysis. Peripheral oxygen saturation was 
measured by pulse oximetry (Biox 3700e; Ohmeda, 
Louisville, CO, USA). Heart rate was determined on the 
basis of the R-R interval from a 4-lead electrocardiogram.
The kinematic data of the chest wall were analyzed 
with an OEP system (BTS Bioengineering, Milan, Italy). A 
complete description of the process has previously been 
published.(20,21) In brief, the volume displacements of 
the two compartments of the chest wall were measured 
through the use of 89 retroreflective markers placed on 
the trunk at established anatomical reference points. (20) 
Three-dimensional coordinates of the markers were 
calculated with stereophotogrammetry and then linked 
with a mesh of triangles representing the surface of 
the trunk. The volume of the trunk enclosed by the 
defined surfaces was obtained through Gauss’ theorem. 
PR program
The PR program consisted of two supervised 60-min 
sessions and one unsupervised 60-min session of 
exercise per week, over a period of eight weeks. Patients 
performed aerobic upper and lower limb exercise, which 
included peripheral muscle strengthening and whole 
body endurance exercises delivered by a combination 
of cycle ergometry and corridor walking exercise. 
The patients trained to a symptom-limited intensity 
equivalent to a level of 3 to 4 on the modified Borg 
scale and were allowed 1-2 min of rest between each 
exercise. Patients were encouraged to increase the time 
spent on each exercise at each session. An individually 
tailored home exercise program was provided for the 
unsupervised session. After each supervised exercise 
session, there was also an education session focusing 
on aspects of behavior and lifestyle. This regime has 
previously been shown to improve exercise capacity 
in patients with a wide range of COPD severity.(22) The 
attendance at each supervised session was documented 
and patients used a home diary to confirm adherence 
with the unsupervised portion of the program.
Data analysis
The chest wall was modeled in two compartments: 
rib cage and abdomen. The total volume displaced 
by the chest wall was calculated as the sum of the 
volumes swept by the two individual compartments. 
The boundaries between those two compartments were 
represented by the lower costal margin. The total lung 
capacity (TLC) was plotted to indicate the operating 
constraints on the chest wall volumes during cycling 
and was obtained as the sum of inspiratory capacity 
and the chest wall volume at the end of expiration.
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We devised an a priori definition of post-PR improve-
ment in exercise performance: an increase in the peak 
workload achieved during the incremental exercise 
test. We also conducted a post-hoc comparison in 
which post-PR improvement was defined as a clinically 
significant increase in the 6MWD.(16) To evaluate the 
physiological responses to PR at equivalent workloads, 
we compared metabolic, ventilatory, and symptomatic 
variables, as well as the operating chest wall volumes, 
during conditions of quiet breathing, unloaded pedaling, 
and equivalent workload (50% and maximum), using 
the shortest cycling test workload as a reference value. 
Thus, for patients who achieved a higher workload after 
PR than before (“improvers”), the selected workload 
was obtained from the pre-PR incremental exercise test, 
whereas for those who did not (“non-improvers”), the 
selected workload was obtained from the post-PR test. 
Statistical analysis
Results are presented as mean ± SD or as median 
and ranges for symptom scores and 6MWD. Values at 
peak exercise were compared by paired t-test and the 
Wilcoxon test for parametric and non-parametric distri-
bution, respectively. Pre- and post-PR time courses on 
incremental exercise test were compared at equivalent 
workload settings with two-way repeated-measures 
analysis of variance. The level of statistical significance 
was set at p < 0.05. The estimation of the sample size 
was impaired because there is lack of studies involving 
OEP and PR. To our knowledge, there have been only 
two studies of OEP and PR in COPD,(1,23) both of which 
investigated the effects of PR on operating volumes. 
Our sample was larger than those evaluated in either 
of those two studies.
RESULTS
Of the 22 patients evaluated, 15 were male. According 
to the Global Initiative for Chronic Obstructive Lung 
Disease staging system,(16) all of the patients had 
moderate to severe COPD (stage II = 5; stage III 
= 12; and stage IV = 5), with substantial resting 
hyperinflation. There were no dropouts. As can be seen 
in Table 1, the overall pre-PR exercise performance 
was markedly impaired, with a mean peak workload < 
25% predicted. Before PR, the mean peak VO2 showed 
a modest relationship with FEV1 as a percentage of 
the predicted value (r = 0.48, p = 0.02). Table 1 also 
shows that cycle exercise was limited by a combination 
of dyspnea and leg fatigue, a high mean pre-PR peak 
minute ventilation (VE)/MVV ratio (88.2 ± 20.1%) 
suggesting that ventilatory limitation was an important 
reason for exercise cessation. In addition, the mean 
pre-PR 6MWD was well below the predicted value (28.7 
± 6.8% of predicted).
There were no significant post-PR changes in 
spirometry parameters or lung volumes at rest 
(Table 1). The mean values for peak ventilation, tidal 
volume, and respiratory rate were similar before and 
after PR, as were the intensity of symptoms and the 
6MWD (Table 1).
Analyzing the equivalent workload conditions, based 
on the highest load achieved in the pre-PR incremental 
exercise test, we found that VO2 and VCO2 were both 
lower after PR, with a corresponding significant drop 
in VE, as shown in Figure S1 of the supplementary file 
(available online at www.jornaldepneumologia/link). This 
post-PR reduction in ventilation was due to decreases 
in tidal volume (−2.7 ± 20.3%) and respiratory rate 
(−5.9 ± 16.3%). There was no significant difference 
between the pre- and post-PR values for the VE/
VCO2 slope (31.8 ± 4.1 vs. 33.3 ± 3.8, p > 0.05). 
Breathlessness and leg fatigue during cycling were 
also similar before and after PR (p > 0.05 for both).
The end-expiratory chest wall volume (EECWV) 
increased during exercise. At peak exercise, the 
end-inspiratory chest wall volume (EICWV) approached 
TLC. The PR program had no effect of the behavior 
on the chest wall volumes or on the timing of the 
increase in the EECWV (Figure 1A). Given the lower 
ventilation after exercise at any given workload, the 
tidal volume was lower and this is in line with the 
decrease in EICWV in the isovolumic comparisons. 
However, the regional distribution of tidal volume 
did change after rehabilitation, despite a significant 
reduction in the volume of the rib cage compartment 
and a non-significant increase in abdominal volume 
(Figures 1B and 1C).
In 16 patients (72.7%), the workload was higher after 
PR than before (46 ± 17 vs. 36 ± 22 W, p < 0.05). The 
gender distribution was comparable between the two 
groups, females accounting for 5 (31.2%) of the 16 
patients in the improver group and for 2 (33.3%) of 
the 6 patients in the non-improver group. Although all 
of the patients attended the same number of training 
sessions, as well as having similar anthropometric 
and spirometric characteristics before PR, the post-PR 
lung volumes (functional residual capacity and TLC) 
tended to be higher in the non-improvers (Table 2). 
There were no significant differences between the 
pre- and post-PR lung function, within or between 
subgroups (p > 0.05 for both). The differences in 
exercise performance between the two subgroups 
were reflected in the 6MWD (Table 3). However the 
post-PR change in the response to the incremental 
exercise test was not very predictive of that, several 
of the patients in the non-improver group showing 
considerable increases in their 6MWD. In comparison 
with the improvers, the non-improvers showed lower 
metabolic and ventilatory responses to incremental 
exercise before PR (p < 0.05) and did not show an 
increase in their whole body VO2 during exercise, as 
can be seen in Figure S2 of the supplementary file 
(available online at www.jornaldepneumologia/link). 
In addition, the non-improvers reported greater leg 
fatigue at maximal exercise in the pre-PR incremental 
exercise test than did the improvers (p < 0.05).
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Although the change in end-exercise total chest wall 
volume under an equivalent workload was no different 
after PR in the improver group or in the non-improver 
group (Figures 2A and 2B, respectively), a significant 
Table 1. Demographic characteristics at baseline, together with BMI, spirometry parameters, and lung volumes, as 
well as exercise performance values (for an incremental exercise test on a cycle ergometer and for the six-minute walk 
test), before and after pulmonary rehabilitation, in patients with COPD (n = 22).a
Variable Pre-PR Post-PR p
Age, years 65.9 ± 7.1
Male gender, n (%) 15 (68.2)
BMI, kg/m2 24.4 ± 5.9 24.7 ± 5.7 0.21
FEV1
L 1.00 ± 0.26 1.01 ± 0.33 0.77
% of the predicted value 37.1 ± 11.8 2.53 ± 0.79 0.72
FVC
L 2.49 ± 0.68 2.53 ± 0.79 0.67
% of the predicted value 66.2 ± 13.5 67.3 ± 15.6 0.71
FEV1/FVC ratio, % 42.5 ± 11.8 41.5 ± 10.0 0.39
IC
L 1.74 ± 0.54 1.79 ± 0.51 0.45
% of the predicted value 64.2 ± 16.0 66.2 ± 16.4 0.32
FRC
L 6.29 ± 2.10 6.10 ± 1.64 0.55
% of the predicted value 189.2 ± 46.3 184.2 ± 38.1 0.57
TLC
L 8.07 ± 2.28 7.84 ± 1.75 0.49
% of the predicted value 128.9 ± 23.4 125.7 ± 17.7 0.51
RV
L 5.35 ± 1.91 5.18 ± 1.45 0.62
% of the predicted value 239.8 ± 69.4 233.9 ± 59.1 0.68
RV/TLC ratio 0.65 ± 0.07 0.65 ± 0.07 0.92
Peak incremental exercise values
Workload
W 33 ± 21 39 ± 20 0.02
% of the predicted value 23.3 ± 13.7 29.0 ± 13.2 0.01
VO2
L/min 0.74 ± 0.18 0.72 ± 0.20 0.43
% of the predicted value 44.7 ± 16.6 42.6 ± 14.4 0.23
VCO2, L/min 0.77 ± 0.22 0.73 ± 0.25 0.15
VE, L/min 32.8 ± 7.2 31.1 ± 9.4 0.07
VE/MVV ratio, % 88.2 ± 20.1 83.2 ± 23.5 0.04
VT, L 1.03 ± 0.31 1.00 ± 0.35 0.34
RR, breaths/min 31 ± 6 30 ± 5 0.7
TI, s 0.81 ± 0.19 0.81 ± 0.18 0.9
TE, s 1.25 ± 0.24 1.26 ± 0.28 0.9
TI/Ttot ratio, % 39.2 ± 4.6 39.2 ± 5.2 0.9
SpO2, % 92 ± 2 94 ± 8 0.3
Post-6MWT values
6MWD
m, median (range) 305 (170-425) 330 (230-490) 0.001
% of the predicted value 28.7 ± 6.8 33.3 ± 8.0 0.001
Borg dyspnea score 3 (1.3) 3 (4.6) 0.8
Borg leg fatigue score 2 (3.0) 1 (4.1) 0.7
SpO2, % 92 ± 2 92 ± 2 0.003
PR: pulmonary rehabilitation; IC: inspiratory capacity; FRC: functional residual capacity; TLC: total lung capacity; 
RV: residual volume; VO2: oxygen consumption; VCO2: carbon dioxide production; VE: minute ventilation; MVV: 
maximal voluntary ventilation; VT: tidal volume; RR: respiratory rate; TI: inspiratory time, TE: expiratory time; Ttot: 
total respiratory time; 6MWT: six-minute walk test; and 6MWD: six-minute walk distance. aValues expressed as 
mean ± SD, except where otherwise indicated.
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post-PR decrease in rib cage operating volume was seen 
in the former and not in the latter (Figures 2C and 2D, 
respectively). In addition, the end-expiratory volume of 
the abdominal compartment during submaximal exercise 
was higher in the improvers than in the non-improvers 
(Figures 2E and 2F, respectively), although the difference 
did not reach statistical significance. We saw the 
same changes in end-expiratory lung volume when 
the response to rehabilitation was categorized by the 
ability to increase walking distance by 30 m or more, 
a recently proposed minimum clinically important 
difference.(16) The ventilatory pattern also differed 
between the two subgroups, the improvers showing 
a post-PR change to a less rapid and less shallow 
breathing pattern at an equivalent VE. 
DISCUSSION
Most patients with COPD report reduced exercise 
tolerance and show varying degrees of dynamic 
hyperinflation during exercise.(24,25) That change has 
been observed even in patients with mild COPD.(26) 
After PR, the rate of rise of end-expiratory lung volume 
during exercise appears to decrease, at least in some 
patients,(2,8) whereas it has also been shown that chest 
wall volumes were reduced after a PR program in 
which the respiratory rate at an equivalent workload 
fell.(1) Our data for COPD patients with even more 
marked resting hyperinflation suggest that this is not 
always the case, even when an equivalent degree of 
improvement in workload is achieved. In addition, 
some of our subjects continued to be limited despite 
PR, possibly as a consequence of hyperinflation and 
the accompanying impairment of the extrapulmonary 
peripheral muscles. 
Our patients are similar to those with severe COPD 
evaluated in other studies, save for their more marked 
degree of resting hyperinflation, with a mean functional 
residual capacity of 6.29 L, compared with the 5.56 
L reported in the literature,(1) which contributed to 
their relatively poor exercise performance. Although 
we followed an incremental exercise test protocol 
similar to that described by Georgiadou et al.,(1) pre-PR 
workloads were higher in the subjects evaluated by 
those authors than in our subjects. Our patients 
exercised with a high fraction of their MVV at peak 
exercise, and their end-inspiratory lung volume reached 
their predicted TLC. After PR, there was a small yet 
statistically significant increase in peak workload 
similar to that reported in other studies employing 
incremental exercise tests,(1,8) and that was reflected 
in a similar improvement in the 6MWD. For a given 
workload, VO2 and VCO2 both decreased after PR in 
our patients, suggesting that a true training effect had 
occurred. However, because the VE/VCO2 slope was not 
changed after PR, it is likely that the lower ventilation 
seen at the equivalent workload was a consequence 
mainly of the lower metabolic stimulus (reduced VCO2).
Like other authors, we observed no relationship 
between the timing of the change in chest wall volume 
and the response to PR. In a recent study, we observed 
that changes in the EECWV during exercise are 
associated with the presence of paradoxical movement 
of the lower rib cage at rest.(27) The data obtained in 
the present study suggest that although this might be 
undesirable in terms of energy expenditure, it does 
not influence the ability to achieve a training effect, 
at least in hyperinflated patients. Although the total 
EECWV was unaffected by PR, there was a post-PR 
decrease in the rib cage volumes, with less recruitment 
of the abdominal compartment during exercise. The 
end-expiratory abdominal volume remained constant 
and there was a proportionate decrease in the volume 
contained within the rib cage compartment at any 
given workload. Although the EECWV was unaffected 
by PR in either subgroup, this new behavior in the rib 
Figure 1. Changes, before and after pulmonary rehabilitation 
(PR), in the inspiratory (operating) volume of the chest 
wall (A), rib cage (B), and abdomen (C) during incremental 
exercise at an equivalent workload, defined as the percentage 
of the maximum workload achieved during the pre-PR 
incremental exercise test. White symbols: before PR; 
black symbols: after PR; ∆V: volume change from resting 
state; TLC (---): total lung capacity, measured before PR; 
triangles: end-inspiratory volumes; circles: end-expiratory 
volumes; QB: quiet breathing; and UP: unloaded pedaling. 
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cage and abdominal compartments after PR, resulting 
in a more physiological pattern and less distortion of 
the total chest wall, was seen only in the improvers. 
However, in the study conducted by Georgiadou et 
al.,(1) who evaluated patients in Athens, Greece, rib 
cage and abdominal volumes at equivalent workloads 
both decreased after PR as a result of a change in 
the breathing pattern and an increase in expiratory 
time. These discrepancies might reflect differences 
in the resting lung volumes, our hyperinflated 
subjects tending to show a reduction in tidal volume 
rather than in the respiratory rate. Another possible 
explanation is that the exercise regimes employed 
may have been different, particularly because some 
of the patients evaluated by Georgiadou et al.(1) 
underwent an interval training regime rather than a 
general physical exercise program.
In the present study, there was a high level of 
adherence to treatment. Nevertheless, some patients 
failed to improve in terms of their response to the 
incremental exercise test or their 6MWD. In general, 
the non-improvers exercised to a lower peak workload 
before PR and tended to have more severe resting 
hyperinflation than did the improvers, although the small 
numbers of patients in each of the subgroups precluded 
any inferences regarding statistical significance. More 
striking was the pre-PR inability of the non-improvers 
to increase their VCO2 during exercise. Previous 
studies have suggested that there are differences 
among patients in terms of the ability of peripheral 
muscles to increase their VO2 during exercise,
(19) 
which could explain why some COPD patients are 
limited by peripheral muscle fatigue rather than by 
ventilatory factors.(28-30) Although we did not collect 
data related to peripheral muscle strength, the fact 
that the non-improvers reported significantly higher 
pre-PR levels of muscle fatigue than did the improvers 
is consistent with such a mechanism. The changes in 
regional operating lung volumes were confined to the 
patients who improved their exercise performance, 
suggesting that such changes were secondary to the 
reduced overall metabolic drive to breathing at any 
given workload. After PR, the improvers had a relatively 
slower and deeper breathing pattern at any VE, which 
could explain why these patients were able to exercise 
for longer without further increasing their reported 
levels of breathlessness. However, whether the change 
in rib cage volume was a result of a reduction in the 
activation of the muscles acting on that compartment 
or a consequence of a reduced central respiratory 
drive cannot be answered on the basis of our findings 
in the present study. In contrast, the non-improvers 
reported higher degrees of muscle fatigue before PR, 
which were still present at lower absolute workloads 
after PR. The fact that the non-improvers showed no 
improvement in VO2 and no decrease in VCO2 could 
Table 2. Comparison between COPD patients who improved after pulmonary rehabilitation and those who did not, in 
terms of baseline age, BMI, spirometry parameters, and lung volumes.a,b
Variable at baseline Post-PR improvers Post-PR non-improvers
(n = 16) (n = 6)
Age, years 65.5 ± 6.8 67.1 ± 8.4
BMI, kg/m2 25.1 ± 6.4 22.5 ± 4.5
FEV1
L 1.01 ± 0.29 1.00 ± 0.19
% of the predicted value 37.4 ± 12.2 36.5 ± 10.1
FVC
L 2.40 ± 0.62 2.73 ± 0.84
% of the predicted value 64.3 ± 12.6 71.5 ± 15.7
FEV1/FVC ratio, % 44.1 ± 12.9 38.3 ± 7.6
IC
L 1.75 ± 0.42 1.61 ± 0.47
% of the predicted value 63.4 ± 12.3 56 ± 10.7
FRC
L 5.67 ± 2.48 6.68 ± 1.02
% of the predicted value 174.3 ± 54.1 204.2 ± 13.0
TLC
L 7.42 ± 2.66 8.29 ± 1.39
% of the predicted value 122.1 ± 26.0 135.2 ± 10.7
RV
L 4.93 ± 2.19 5.48 ± 0.82
% of the predicted value 228.0 ± 82.6 242.0 ± 23.7
RV/TLC ratio, % 64.8 ± 7.3 66.7 ± 9.1
PR: pulmonary rehabilitation; IC: inspiratory capacity; FRC: functional residual capacity; TLC: total lung capacity; 
and RV: residual volume. aValues expressed as mean ± SD. bThere were no statistical differences between the two 
subgroups for any of these variables.
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explain why they also showed no post-PR changes in 
VE or regional chest wall volumes.
Our study has certain limitations. We used a 
relatively arbitrary threshold to define improvers 
and non-improvers in terms of the response to the 
incremental exercise test, given that there is no 
established minimum clinically important difference 
for that test. However, our findings were unchanged 
when we separated patients according to the ability 
to achieve a clinically important improvement in the 
6MWD after PR. In addition, the protocol involved 
incremental rather than constant-load exercise, which 
could have decreased its sensitivity to detect post-PR 
improvements in exercise capacity. Nevertheless, the 
use of incremental exercise allowed us to analyze 
variables at different exercise intensities over the 
course of the test. Furthermore, we did not specifically 
identify peripheral muscle weakness, although that 
would be a plausible explanation for the differences 
we observed. Future studies of COPD patients who 
do not improve after PR, however they are defined, 
should include objective measurements of peripheral 
muscle fatigue. The small number of patients who 
did not improve after our PR is encouraging given our 
selection of individuals with significant hyperinflation. 
Finally, we did not measure ventilatory muscle strength, 
which could have had some effect on the operating 
volumes during exercise.
In summary, we have shown that in COPD patients 
with resting hyperinflation the major effect that PR 
has on exercise capacity is that of improving VO2 
and reducing VCO2, with a commensurate decrease 
in respiratory drive. The changes in operating lung 
volumes reflect this reduction in respiratory drive for a 
given workload. When severe hyperinflation is present, 
the ability to reduce operating lung volumes with a 
reduction in respiratory drive is more limited, although 
subtle changes in the distribution of volume between 
the rib cage and abdominal compartments could be a 
useful way to delay the onset of limiting symptoms. 
Such changes occurred only in patients in whom an 
objective training effect could be demonstrated. It is 
encouraging to see that a majority of patients with 
severe COPD can improve after completing a conven-
tional non-specific exercise program. However, certain 
patients (those with significant resting hyperinflation) 
might require a different approach to rehabilitation 
and those in whom breathlessness or leg fatigue is a 
dominant symptom at low workloads might require 
specific peripheral muscle training. 
Table 3. Comparison between COPD patients who improved after pulmonary rehabilitation and those who did not, 






(n = 16) (n = 6)
Pre-PR Post-PR Pre-PR Post-PR
Peak incremental exercise values
Workload
W 36 ± 22 46 ± 17* 27 ± 18 21 ± 13†
% of the predicted value 24.8 ± 14.3 34.2 ± 10.3* 19.1 ± 12 15.1 ± 9.6
VO2, L/min 0.76 ± 0.18 0.77 ± 0.21 0.70 ± 0.19 0.60 ± 0.15
VCO2, L/min 0.81 ± 0.23 0.80 ± 0.25 0.69 ± 0.20 0.53 ± 0.12
†
VE, L/min 33.7 ± 8.1 33.7 ± 9.7 30.4 ± 3.6 24.3 ± 4.1*
VE/MVV ratio, % 87.9 ± 18.6 87.0 ± 21.2 89.1 ± 25.7 72.8 ± 28.3*
VT, L 1.08 ± 0.34 1.09 ± 0.37 0.92 ± 0.20 0.76 ± 0.14
†
RR, breaths/min 32 ± 6 30 ± 6 30 ± 3 30 ± 4
TI, s 0.79 ± 0.19 0.81 ± 0.18 0.86 ± 0.18 0.83 ± 0.21
TE, s 1.24 ± 0.27 1.27 ± 0.31 1.25 ± 0.15 1.22 ± 0.19
TI/Ttot ratio 0.39 ± 0.04 0.39 ± 0.05 0.39 ± 0.05 0.39 ± 0.06
SpO2, % 93 ± 2 94 ± 2 92 ± 2 92 ± 1
Post-6MWT values
6MWD
m, median (range) 310 (170-425) 338 (230-490)* 285 (190-340) 290 (230-466)
% of the predicted value 29.8 ± 7.2 34.5 ± 7.7* 25.7 ± 5.0 30.2 ± 8.7
Borg dyspnea score, median (range) 3 (0-5) 3 (0.5-5) 3.5 (2-5) 3 (2-9)
Borg leg fatigue score, median (range) 2 (0-5) 1 (0-5) 1.75 (0-4) 1.5 (0-7)
SpO2, % 92 ± 3 90 ± 4* 92 ± 1 88 ± 2
PR: pulmonary rehabilitation; VO2: oxygen consumption; VCO2: carbon dioxide production; VE: minute ventilation; 
MVV: maximal voluntary ventilation; VT: tidal volume; RR: respiratory rate; TI: inspiratory time, TE: expiratory 
time; Ttot: total respiratory time; 6MWT: six-minute walk test; and 6MWD: six-minute walk distance. aValues 
expressed as mean ± SD, except where otherwise indicated. *p < 0.05 vs. pre-PR value. †p < 0.05 vs. post-PR 
improvers.
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